Please wait while the formulary information is being retrieved.
PROVENGE (SIPULEUCEL-T/LACTATED RINGERS SOLUTION)
- Metastatic prostate carcinoma
50 million cell/250 mL intravenous suspension
- Dosage information is not available
- natalizumab
- Tysabri
Contraindicated
- ceftriaxone
- ceftriaxone in dextrose,iso-os
- Digox
- digoxin
- Lanoxin
- Lanoxin Pediatric
- Rocephin
Severe
Moderate
- None
- Mitochondrial disease
Contraindicated
- None
Severe
Moderate
- Cardiac arrhythmia
- Cardiac disease
- Pulmonary disease
PROVENGE (SIPULEUCEL-T/LACTATED RINGERS SOLUTION)
- Metastatic prostate carcinoma
- Bronchospastic pulmonary disease
- Dyspnea
- Hypoxia
- Arthralgias
- Back pain
- Chills
- Fatigue
- Fever
- Headache disorder
- Hypersensitivity drug reaction
- Nausea
More Frequent
Severe
Less Severe
- Hypertension
- Dizziness
- Flu-like symptoms
- General weakness
- Hematuria
- Hyperhidrosis
- Muscle spasm
- Myalgias
- Pain
- Skin rash
- Tremor
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Cerebrovascular accident
Less Severe
- None
Contraindicated
None
Severe Precaution
Sipuleucel-T
Not indicated in pediatrics. No safety data.
- 1 Day – 18 Years
- Not indicated in pediatrics. No safety data.
Management or Monitoring Precaution
None
Sipuleucel-t
- Severity Level:
2
- Additional Notes: Manufacturer does not provide any pregnancy warning information
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Sipuleucel-t
None
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Sipuleucel-t
Cardiovascular-Increased DVT/PE risk in patients with predisposing conditions. Hemorrhagic and ischemic stroke have been observed in patients with predisposing factors. Gastrointestinal-Risk of constipation. In clinical trials, 11% of patients experienced constipation of any grade.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | Y | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Metastatic prostate carcinoma | |
| C61 | Malignant neoplasm of prostate |
| 0-9 | A-Z |
|---|---|
| C61 | Malignant neoplasm of prostate |
Formulary Reference Tool